We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Ranked Momentum Stocks to Buy for December 4th
Read MoreHide Full Article
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 4th:
Cassava Sciences, Inc. (SAVA - Free Report) : This clinical-stage drug development company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 28.9% over the last 60 days.
China Automotive Systems, Inc. (CAAS - Free Report) : This manufacturer and seller of automotive systems and components has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 87.5% over the last 60 days.
China Automotive Systems, Inc. Price and Consensus
Galmed Pharmaceuticals Ltd. (GLMD - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 13.9% over the last 60 days.
Globalstar, Inc. (GSAT - Free Report) : This provider of mobile satellite voice and data communication services has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for December 4th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 4th:
Cassava Sciences, Inc. (SAVA - Free Report) : This clinical-stage drug development company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 28.9% over the last 60 days.
Pain Therapeutics Price and Consensus
Pain Therapeutics price-consensus-chart | Pain Therapeutics Quote
Cassava Sciences’ shares gained 31.8% over the last one month above the S&P 500’s increase0.5%. The company possesses a Momentum Score of B.
Pain Therapeutics Price
Pain Therapeutics price | Pain Therapeutics Quote
China Automotive Systems, Inc. (CAAS - Free Report) : This manufacturer and seller of automotive systems and components has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 87.5% over the last 60 days.
China Automotive Systems, Inc. Price and Consensus
China Automotive Systems, Inc. price-consensus-chart | China Automotive Systems, Inc. Quote
China Automotive Systems’ shares gained 93.4% over the last one month. The company possesses a Momentum Score of B.
China Automotive Systems, Inc. Price
China Automotive Systems, Inc. price | China Automotive Systems, Inc. Quote
Galmed Pharmaceuticals Ltd. (GLMD - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 13.9% over the last 60 days.
Galmed Pharmaceuticals Ltd. Price and Consensus
Galmed Pharmaceuticals Ltd. price-consensus-chart | Galmed Pharmaceuticals Ltd. Quote
Galmed Pharmaceuticals’ shares gained 18.8% over the last one month. The company possesses a Momentum Score of B.
Galmed Pharmaceuticals Ltd. Price
Galmed Pharmaceuticals Ltd. price | Galmed Pharmaceuticals Ltd. Quote
Globalstar, Inc. (GSAT - Free Report) : This provider of mobile satellite voice and data communication services has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Globalstar, Inc. Price and Consensus
Globalstar, Inc. price-consensus-chart | Globalstar, Inc. Quote
Globalstar’s shares gained 0.5% over the last one month. The company possesses a Momentum Score of B.
Globalstar, Inc. Price
Globalstar, Inc. price | Globalstar, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>